Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Impax drops 11% on downgrade
Marketwatch
Wednesday, June 8, 2011 - 10:48am
tags:
downgrades, Impax
Pfizer Fired Rep Who Hid From Domestic Violence
Pharmalot
Wednesday, June 8, 2011 - 10:21am
tags:
Pfizer, drug reps, firings
Watson to Market Generic Lybrel
Yahoo/Zacks.com
Wednesday, June 8, 2011 - 10:04am
tags:
Watson Pharmaceuticals, generics, birth control pill, Lybrel
Pharmasset shares climb after company expands study of hepatitis C drug candidate PSI-7977
Yahoo/AP
Wednesday, June 8, 2011 - 9:36am
tags:
Pharmasset, hepatitis C, PSI-7977
Somaxon and Paladin Announce Silenor® Ex-US Collaboration
Yahoo
Wednesday, June 8, 2011 - 9:13am
tags:
Silenor, insomnia, Paladin, Somaxon, Canada, Africa, South America
Dendreon to test Provenge in early-stage cancer
Fierce Pharma
Wednesday, June 8, 2011 - 8:57am
tags:
Provenge, Dendreon, prostate cancer, vaccines
Lundbeck Wants To Stop US Prisons Getting Epilepsy Drug
WSJ Online
Wednesday, June 8, 2011 - 8:56am
tags:
epilepsy, Lundbeck, execution drugs
Biogen Seeking Deals to Expand Pipeline of MS Treatments
Bloomberg
Wednesday, June 8, 2011 - 8:53am
tags:
MS, multiple sclerosis, Biogen Idec
Covidien Said to Work With JPMorgan Seeking Buyer for Drug Unit
Bloomberg
Wednesday, June 8, 2011 - 8:52am
tags:
Covidien, M&A
India Proposes Tougher Code On Pharma Freebies
Pharmalot
Wednesday, June 8, 2011 - 8:51am
tags:
India, physician gifts
Pharmacyclics Shares Popped: What You Need to Know
Motley Fool
Wednesday, June 8, 2011 - 8:50am
tags:
Pharmacyclics, tyrosine kinases
Health-Care Law Must Stand, U.S. Says in Third Appeal Argument
Bloomberg
Wednesday, June 8, 2011 - 8:31am
tags:
healthcare reform
Biomarin - Fair Value of $50+: A Step-by-Step Analysis
Seeking Alpha
Wednesday, June 8, 2011 - 8:30am
tags:
Biomarin
Merck ends trial of Intercell's MRSA vaccine
Yahoo/AP
Wednesday, June 8, 2011 - 8:29am
tags:
Intercell, vaccines, Merkc, MRSA, V710
A Dull ASCO And The Usual Sell-Off
Investopedia
Tuesday, June 7, 2011 - 7:34pm
tags:
ASCO, Celgene, Bristol-Myers Squibb, Incyte, Exelixis, Novartis, YM BioSciences, Neoprobe
ASCO studies shake up drug stocks
Marketwatch
Tuesday, June 7, 2011 - 6:22pm
tags:
ASCO, drug stocks, Sunesis, Exelixis, Bayer, Oxigene, Regeneron, EntreMed
Merck and Roche: Sometimes a Partnership Feels Personal
Motley Fool
Tuesday, June 7, 2011 - 6:18pm
tags:
Merck, Roche, cancer, diagnostics
Pfizer starts first US "virtual" clinical study, under pilot FDA program using Internet
Yahoo/AP
Tuesday, June 7, 2011 - 6:16pm
tags:
clinical studies, Pfizer, FDA, Detrol, overactive bladder
APP launches generic version of Femara, drug linked to lower breast cancer risk in new study
Yahoo/AP
Tuesday, June 7, 2011 - 6:15pm
tags:
APP, Femara, breast cancer, generics, Novartis
Pfizer May Seek $1 Billion in Yearly Cost Cuts, WSJ Says
Bloomberg
Tuesday, June 7, 2011 - 6:14pm
tags:
Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.